Quản lý ngoại khoa cho bệnh nhân chấn thương trong điều trị bằng thuốc chống đông đường uống trực tiếp

Beyer-Westendorf J, Gelbricht V, Förster K et al (2014) Peri-interventional management of novel oral anticoagulants in daily care: Results from the prospective Dresden NOAC registry. Eur Heart J 35(28):1888–1896. https://doi.org/10.1093/eurheartj/eht557 Colonna P, von Heymann C, Santamaria A, Matsushita Y, Unverdorben M (2018) Edoxaban management in diagnostic and therapeutic procedures (EMIT-AF/VTE)-trial design. Clin Cardiol 41(9):1123–1129. https://doi.org/10.1002/clc.23037 Statistisches Bundesamt (2017) Fallpauschalenbezogene Krankenhausstatistik 2016. Fachserie 12, Reihe 6.4. Destatis, Wiesbaden Bauer M, Waeschle RM, Rüggeber J, Meyer HJ, Taube C, Diemer M, Schuster M (2016) Glossar perioperativer Prozesszeiten und Kennzahlen. Eine gemeinsame Empfehlung von BDA / DGAI, BDC / DGCH und VOPM. Anasth Intensivmed 57:669–683 Koscielny J, Rosenthal C, von Heymann C (2018) Blutungsmanagement unter direkten oralen Antikoagulanzien (DOAK). Dtsch Med Wochenschr 143(24):1734–1738. https://doi.org/10.1055/a-0585-8166 Maegele M, Grottke O, Schöchl H, Sakowitz OA, Spannagl M, Koscielny J (2016) Direct oral anticoagulants in emergency trauma admissions. Dtsch Arztebl Int 113(35–36):575–582. https://doi.org/10.3238/arztebl.2016.0575 Steffel J, Verhamme P, Potpara TS et al (2018) The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39(16):1330–1393. https://doi.org/10.1093/eurheartj/ehy136 Altiok E, Marx N (2018) Oral anticoagulation. Dtsch Arztebl Int 115(46):776–783. https://doi.org/10.3238/arztebl.2018.0776 Beyer-Westendorf J, Klamroth R, Kreher S, Langer F, Matzdorff A, Riess H (2019) Non-vitamin K antagonist oral anticoagulants (NOAC) as an alternative treatment option in tumor-related venous thromboembolism. Dtsch Arztebl Int 116(3):31–38. https://doi.org/10.3238/arztebl.2019.0031 Koscielny J, Rosenthal C, von Heymann C (2017) Update Direkte Orale AntiKoagulanzien (DOAKs) – Perioperatives „Switching“, Medikamenteninteraktionen und Persistenz. Hamostaseologie 37(4):267–275. https://doi.org/10.5482/HAMO-16-10-0041 Douketis J, Spyropoulos AC, Duncan JM et al (2018) Perioperative anticoagulant use for surgery evaluation (PAUSE) study: A perioperative management plan for patients with atrial fibrillation who are receiving a direct oral anticoagulant. Blood 132:LBA-5. https://doi.org/10.1182/blood-2018-120770 Douketis JD, Spyropoulos AC, Anderson JM et al (2017) The Perioperative anticoagulant use for surgery evaluation (PAUSE) study for patients on a direct oral anticoagulant who need an elective surgery or procedure: Design and rationale. Thromb Haemost 117(12):2415–2424. https://doi.org/10.1160/TH17-08-0553 Douketis JD, Spyropoulos AC, Anderson JM et al (2018) Erratum to: The perioperative anticoagulant use for surgery evaluation (PAUSE) study for patients on a direct oral anticoagulant who need an elective surgery or procedure: Design and rationale. Thromb Haemost 118(9):1679–1680. https://doi.org/10.1055/s-0038-1668582 Schulman S, Angerås U, Bergqvist D, Eriksson B, Lassen MR, Fisher W (2010) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 8(1):202–204. https://doi.org/10.1111/j.1538-7836.2009.03678.x Chaput AJ, Bryson GL (2012) Postoperative delirium: Risk factors and management: Continuing professional development. Can J Anaesth 59(3):304–320. https://doi.org/10.1007/s12630-011-9658-4 Waydhas C (2014) Perioperatives Management bei Patienten mit Gerinnungshemmern. Orthop Unfallchir 03(02):144–150 Faraoni D, Levy JH, Albaladejo P, Samama C‑M (2015) Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants. Crit Care 19:203–208. https://doi.org/10.1186/s13054-015-0930-9 Giebl A, Gürtler K (2014) Neue orale Antikoagulanzien in der perioperativen Medizin [New oral anticoagulants in perioperative medicine]. Anaesthesist 63(4):347–362. https://doi.org/10.1007/s00101-014-2314-y (quiz 363–4) Lindhoff-Last E (2017) Direct oral anticoagulants (DOAC)—Management of emergency situations. Hamostaseologie 37(04):257–266. https://doi.org/10.5482/HAMO-16-11-0043 Horlocker TT, Vandermeuelen E, Kopp SL, Gogarten W, Leffert LR, Benzon HT (2018) Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American society of regional anesthesia and pain medicine evidence-based guidelines (fourth edition). Reg Anesth Pain Med 43(3):263–309. https://doi.org/10.1097/AAP.0000000000000763 Waurick K, Riess H, van Aken H, Kessler P, Gogarten W, Volk T (2014) Rückenmarksnahe Regionalanästhesien und Thromboembolieprophylaxe/ antithrombotische Medikation. S1-Leitlinie 001/005 (https://www.awmf.org/leitlinien/detail/ll/001-005.html) Kozek S, Gütl M, Illievich U, Pachucki A, Kwasny O, Giurea A, Haushofer A, Watzke H (2016) Klinischer Pfad – Behandlung hüftnaher Frakturen bei zuvor oral antikoagulierten Patientinnen und Patienten inkl. Ergänzungen. Bundesministerium für Gesundheit, Wien Levy JH, Ageno W, Chan NC, Crowther M, Verhamme P, Weitz JI (2016) When and how to use antidotes for the reversal of direct oral anticoagulants: Guidance from the SSC of the ISTH. J Thromb Haemost 14(3):623–627. https://doi.org/10.1111/jth.13227 Piran S, Khatib R, Schulman S et al (2019) Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: A meta-analysis. Blood Adv 3(2):158–167. https://doi.org/10.1182/bloodadvances.2018024133